These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29116116)

  • 1. Urinary sulphatoxymelatonin as a biomarker of serotonin status in biogenic amine-deficient patients.
    Batllori M; Molero-Luis M; Arrabal L; Heras JL; Fernandez-Ramos JA; Gutiérrez-Solana LG; Ibáñez-Micó S; Domingo R; Campistol J; Ormazabal A; Sedel F; Opladen T; Zouvelou B; Pons R; Garcia-Cazorla A; Lopez-Laso E; Artuch R
    Sci Rep; 2017 Nov; 7(1):14675. PubMed ID: 29116116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.
    Kennedy SH; Davis BA; Brown GM; Ford CG; d'Souza J
    Neurochem Res; 1993 Dec; 18(12):1281-5. PubMed ID: 7505890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease.
    Girotti L; Lago M; Ianovsky O; Carbajales J; Elizari MV; Brusco LI; Cardinali DP
    J Pineal Res; 2000 Oct; 29(3):138-42. PubMed ID: 11034110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual changes in 6-sulphatoxymelatonin excretion in man.
    Bojkowski CJ; Arendt J
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):470-6. PubMed ID: 3389039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function.
    Baskett JJ; Cockrem JF; Antunovich TA
    J Pineal Res; 1998 Jan; 24(1):58-61. PubMed ID: 9468119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary 6-sulphatoxymelatonin levels are depressed in chronic migraine and several comorbidities.
    Masruha MR; Lin J; de Souza Vieira DS; Minett TS; Cipolla-Neto J; Zukerman E; Vilanova LC; Peres MF
    Headache; 2010 Mar; 50(3):413-9. PubMed ID: 19817880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal 24-hour urinary excretory pattern of 6-sulphatoxymelatonin in both phases of cluster headache.
    Leone M; Lucini V; D'Amico D; Grazzi L; Moschiano F; Fraschini F; Bussone G
    Cephalalgia; 1998 Dec; 18(10):664-7. PubMed ID: 9950622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of biogenic amines affecting the metabolism of serotonin and catecholamines.
    Lamers KJ; Wevers RA
    Mult Scler; 1998 Feb; 4(1):37-8. PubMed ID: 9532591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder.
    Tordjman S; Anderson GM; Pichard N; Charbuy H; Touitou Y
    Biol Psychiatry; 2005 Jan; 57(2):134-8. PubMed ID: 15652871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of sympathectomy in humans on the rhythmicity of 6-sulphatoxymelatonin urinary excretion.
    Møller M; Osgaard O; Grønbech-Jensen M
    Mol Cell Endocrinol; 2006 Jun; 252(1-2):40-5. PubMed ID: 16647807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring Urinary 6-Sulphatoxymelatonin in Humans.
    St Hilaire MA; Lockley SW
    Methods Mol Biol; 2022; 2550():21-28. PubMed ID: 36180673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine sepiapterin excretion as a new diagnostic marker for sepiapterin reductase deficiency.
    Carducci C; Santagata S; Friedman J; Pasquini E; Carducci C; Tolve M; Angeloni A; Leuzzi V
    Mol Genet Metab; 2015 Aug; 115(4):157-60. PubMed ID: 26123188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The purification and characterization of biological 6-sulphatoxymelatonin and comparison with synthetic 6-sulphatoxymelatonin.
    Street CA; Di WL; Peniston-Bird JF; Patel S; Sadler P; Silman RE
    J Pineal Res; 1996 Mar; 20(2):98-114. PubMed ID: 8815194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense blue light therapy during the night-time does not suppress the rhythmic melatonin biosynthesis in a young boy.
    Stebelova K; Kosnacova J; Zeman M
    Endocr Regul; 2017 Jan; 51(1):31-34. PubMed ID: 28222021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin agonists mimic the phase shifting effects of light on the melatonin rhythm in rats.
    Kennaway DJ; Rowe SA; Ferguson SA
    Brain Res; 1996 Oct; 737(1-2):301-7. PubMed ID: 8930380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine neurotransmitter deficiencies.
    Pearl PL
    Handb Clin Neurol; 2013; 113():1819-25. PubMed ID: 23622404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals.
    Mulder EJ; Anderson GM; Kemperman RF; Oosterloo-Duinkerken A; Minderaa RB; Kema IP
    Neuropsychobiology; 2010; 61(1):27-32. PubMed ID: 19923863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis.
    Hyland K; Surtees RA; Rodeck C; Clayton PT
    Neurology; 1992 Oct; 42(10):1980-8. PubMed ID: 1357595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary 6-sulphatoxymelatonin levels and sleep disorders in children with migraine.
    Abou-Khadra MK; Kishk NA; Shaker OG; Hassan A
    J Child Neurol; 2014 Jul; 29(7):947-51. PubMed ID: 24014264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin alterations and brain acetylcholine lesions in sleep disorders in Cockayne syndrome.
    Okoshi Y; Tanuma N; Miyata R; Hayashi M
    Brain Dev; 2014 Nov; 36(10):907-13. PubMed ID: 24503446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.